+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ankylosing Spondylitis Drug"

Ankylosing Spondylitis Market Forecast to 2033 - Product Thumbnail Image

Ankylosing Spondylitis Market Forecast to 2033

  • Report
  • October 2025
  • 150 Pages
  • Global
From
Ankylosing Spondylitis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ankylosing Spondylitis Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Ankylosing Spondylitis - Global Strategic Business Report - Product Thumbnail Image

Ankylosing Spondylitis - Global Strategic Business Report

  • Report
  • September 2026
  • 271 Pages
  • Global
From
Ankylosing Spondylitis Market Report 2026 - Product Thumbnail Image

Ankylosing Spondylitis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Ankylosing Spondylitis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Thumbnail Image

Ankylosing Spondylitis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • May 2026
  • 182 Pages
  • Global
From
Ankylosing Spondylitis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Ankylosing Spondylitis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • August 2026
  • 120 Pages
  • Global
From
Ankylosing Spondylitis Treatment Market Outlook 2026-2034: Market Share and Growth Analysis by Drug Class (NSAIDs, TNF Inhibitors, IL-17 Inhibitors, JAK Inhibitors, Biosimilars, Others), Route of Administration, Distribution Channel - Product Thumbnail Image

Ankylosing Spondylitis Treatment Market Outlook 2026-2034: Market Share and Growth Analysis by Drug Class (NSAIDs, TNF Inhibitors, IL-17 Inhibitors, JAK Inhibitors, Biosimilars, Others), Route of Administration, Distribution Channel

  • Report
  • April 2026
  • 160 Pages
  • Global
From
Rheumatology Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Rheumatology Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Musculoskeletal System Disorder Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Musculoskeletal System Disorder Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Tofacitinib Citrate Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Tofacitinib Citrate Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 183 Pages
  • Global
From
Meloxicam Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Meloxicam Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
Aceclofenac Tablets Market - Global Forecast 2026-2032 - Product Thumbnail Image

Aceclofenac Tablets Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Arthritic Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Arthritic Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • October 2025
  • 150 Pages
  • Global
From
Remicade Market Size, Share & Trends Analysis Report by Type (Branded, Biosimilar), Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Remicade Market Size, Share & Trends Analysis Report by Type (Branded, Biosimilar), Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • May 2025
  • 100 Pages
  • Global
From
Humira Market Size, Share & Trends Analysis Report by Product (Branded, Biosimilar), Application (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Thumbnail Image

Humira Market Size, Share & Trends Analysis Report by Product (Branded, Biosimilar), Application (Rheumatoid Arthritis, Psoriatic Arthritis, Crohn's Disease), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • May 2025
  • 100 Pages
  • Global
From
Ankylosing Spondylitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031 - Product Thumbnail Image

Ankylosing Spondylitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023-2031

  • Report
  • January 2024
  • 113 Pages
  • Global
From
Ankylosing Spondylitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ankylosing Spondylitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (Bekhterev's Disease) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • February 2022
  • 105 Pages
  • Global
From
Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • February 2022
  • 210 Pages
  • Global
From
Loading Indicator

The Ankylosing Spondylitis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Ankylosing Spondylitis is a chronic inflammatory disorder that affects the spine and other joints, and is characterized by pain and stiffness. Ankylosing Spondylitis Drugs are used to reduce inflammation and pain, and to improve mobility. These drugs are typically administered orally or by injection, and may include biologics, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroids. The Ankylosing Spondylitis Drug market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include AbbVie, Amgen, Pfizer, Janssen, and Novartis. Show Less Read more